Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 140
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04118114 | Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors | ||
| NCT01394315 | Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer | ||
| NCT04738708 | Telegenetics or In-Person Genetic Counselling | ||
| NCT02420067 | Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients | ||
| NCT07234357 | Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia | ||
| NCT04995185 | 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study | ||
| NCT07241715 | Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE) | ||
| NCT01540110 | Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses | ||
| NCT05211882 | ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in Singapore | ||
| NCT02368860 | OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma | ||
| NCT01022723 | Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells | ||
| NCT03100006 | Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin | ||
| NCT07428356 | Histotripsy for Ablation of Liver Tumours in Asia | ||
| NCT03267641 | Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma | ||
| NCT06294808 | Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC | ||
| NCT01716689 | Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas | ||
| NCT04087473 | Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC | ||
| NCT04452084 | Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT | ||
| NCT04224480 | Longitudinal Immune-phenotyping of HCC Following MK-3475 | ||
| NCT00957086 | Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer | ||
| NCT02808091 | Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma | ||
| NCT04986748 | Using QPOP to Predict Treatment for Sarcomas and Melanomas | ||
| NCT04660188 | Impact of a Breast cAncer Survivorship Interprofessional Community Care Model | ||
| NCT07583979 | Electroacupuncture for Cognitive Toxicity in Cancer Survivors: Assessing Implementation, Cost, and Effectiveness for Integration | ||
| NCT07133269 | Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients | ||
| NCT00731276 | Irinotecan in Treating Asian Patients With Solid Tumors | ||
| NCT01570296 | A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR | ||
| NCT00589186 | Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer | ||
| NCT04946968 | Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers | ||
| NCT02313298 | Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer | ||
| NCT05377034 | Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients | ||
| NCT03330509 | Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospital | ||
| NCT03670342 | Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer | ||
| NCT05724264 | SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE) | ||
| NCT07013461 | International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer | ||
| NCT00263484 | Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma | ||
| NCT04912765 | Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC | ||
| NCT05929885 | Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients | ||
| NCT04664829 | The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC | ||
| NCT01765686 | Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery | ||
| NCT04620954 | Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin | ||
| NCT04632173 | Head and Neck cancERs International cOviD-19 collabOraTion | ||
| NCT04072107 | EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR) | ||
| NCT06172595 | FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma | ||
| NCT00702481 | Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer | ||
| NCT06418412 | A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC | ||
| NCT04340024 | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | ||
| NCT02931864 | Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors | ||
| NCT05355558 | A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer | ||
| NCT00589238 | Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery |
